Frontiers in Immunology (Feb 2021)

Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease Patients

  • Ahmed S. Fahad,
  • Morgan R. Timm,
  • Bharat Madan,
  • Katherine E. Burgomaster,
  • Kimberly A. Dowd,
  • Erica Normandin,
  • Matías F. Gutiérrez-González,
  • Joseph M. Pennington,
  • Matheus Oliveira De Souza,
  • Amy R. Henry,
  • Farida Laboune,
  • Lingshu Wang,
  • David R. Ambrozak,
  • Ingelise J. Gordon,
  • Daniel C. Douek,
  • Julie E. Ledgerwood,
  • Barney S. Graham,
  • Leda R. Castilho,
  • Theodore C. Pierson,
  • John R. Mascola,
  • Brandon J. DeKosky,
  • Brandon J. DeKosky

DOI
https://doi.org/10.3389/fimmu.2021.615102
Journal volume & issue
Vol. 12

Abstract

Read online

The re-emergence of Zika virus (ZIKV) caused widespread infections that were linked to Guillain-Barré syndrome in adults and congenital malformation in fetuses, and epidemiological data suggest that ZIKV infection can induce protective antibody responses. A more detailed understanding of anti-ZIKV antibody responses may lead to enhanced antibody discovery and improved vaccine designs against ZIKV and related flaviviruses. Here, we applied recently-invented library-scale antibody screening technologies to determine comprehensive functional molecular and genetic profiles of naturally elicited human anti-ZIKV antibodies in three convalescent individuals. We leveraged natively paired antibody yeast display and NGS to predict antibody cross-reactivities and coarse-grain antibody affinities, to perform in-depth immune profiling of IgM, IgG, and IgA antibody repertoires in peripheral blood, and to reveal virus maturation state-dependent antibody interactions. Repertoire-scale comparison of ZIKV VLP-specific and non-specific antibodies in the same individuals also showed that mean antibody somatic hypermutation levels were substantially influenced by donor-intrinsic characteristics. These data provide insights into antiviral antibody responses to ZIKV disease and outline systems-level strategies to track human antibody immune responses to emergent viral infections.

Keywords